See more : Tsakos Energy Navigation Limited (TNP-PE) Income Statement Analysis – Financial Results
Complete financial analysis of P3 Health Partners Inc. (PIII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of P3 Health Partners Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Tianjin Printronics Circuit Corporation (002134.SZ) Income Statement Analysis – Financial Results
- PZ Cormay S.A. (CRM.WA) Income Statement Analysis – Financial Results
- TINC NV (TINC.BR) Income Statement Analysis – Financial Results
- Newebinfo (6938.TWO) Income Statement Analysis – Financial Results
- Ningbo Donly Co.,Ltd (002164.SZ) Income Statement Analysis – Financial Results
P3 Health Partners Inc. (PIII)
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.05B | 491.06B | 485.54M | 145.48M | 87.70M |
| Cost of Revenue | 1.23B | 1.14B | 668.07M | 485.30M | 141.03M | 0.00 |
| Gross Profit | 31.64M | -95.01M | 490.40B | 243.70K | 4.45M | 87.70M |
| Gross Profit Ratio | 2.50% | -9.05% | 99.86% | 0.05% | 3.06% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.36M | 157.30M | 53.39B | 53.39M | 36.42M | 28.54M |
| Selling & Marketing | 3.23M | 5.10M | 1.50B | 1.50M | 801.69K | 1.87M |
| SG&A | 125.60M | 162.40M | 54.89B | 54.89M | 37.23M | 30.41M |
| Other Expenses | 73.97M | 1.13B | 464.76B | 465.77M | 147.79M | -103.73K |
| Operating Expenses | 199.57M | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Cost & Expenses | 1.43B | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Interest Income | 0.00 | 11.40M | 0.00 | 2.53M | 2.53M | 0.00 |
| Interest Expense | 15.99M | 11.40M | 10.68M | 2.53M | 2.53M | 0.00 |
| Depreciation & Amortization | 86.68M | 87.29M | 8.72M | 795.17K | 399.18K | 342.20K |
| EBITDA | -81.07M | -1.46B | -184.61M | -28.08M | -39.04M | -49.37M |
| EBITDA Ratio | -6.40% | -14.85% | -6.40% | -7.07% | -26.83% | -56.30% |
| Operating Income | -167.86M | -1.56B | -31.41B | -35.12M | -39.54M | -49.71M |
| Operating Income Ratio | -13.26% | -148.73% | -6.40% | -7.23% | -27.18% | -56.69% |
| Total Other Income/Expenses | -15.87M | 1.22M | -31.22B | -2.82M | -2.44M | -59.50K |
| Income Before Tax | -183.73M | -1.56B | -31.41B | -45.38M | -41.97M | -49.77M |
| Income Before Tax Ratio | -14.51% | -148.60% | -6.40% | -9.35% | -28.85% | -56.76% |
| Income Tax Expense | 2.70M | 1.90M | -31.40B | -4.00M | 2.63M | -6.02M |
| Net Income | -57.77M | -270.13M | -10.08M | -31.41M | -41.97M | -43.80M |
| Net Income Ratio | -4.56% | -25.74% | 0.00% | -6.47% | -28.85% | -49.95% |
| EPS | -0.61 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| EPS Diluted | -0.20 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| Weighted Avg Shares Out | 94.89M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
| Weighted Avg Shares Out (Dil) | 294.59M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on...
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Leif Pedersen - Chief Financial Officer Amir Bacchus - Chief...
P3 Health Partners Inc. (PIII) Reports Q3 Loss, Misses Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 30, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partners
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
P3 Health Partners Schedules Third Quarter 2024 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2024 and file its Quarterly Report on Form 10-Q...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
Source: https://incomestatements.info
Category: Stock Reports